All scientific matters are handled by the Executive Scientific Committee (ESC) appointed by the Board of Directors.
Created on July 8th 2015, the ESC is composed of internationally recognized researchers, who have been conducting Breast Cancer research protocols for many years and who wish to increase the accessibility of patients to these protocols. Each of the Founding institutions and Associated members has a seat on the Committee as well as one representative of the Affiliated members who is appointed by the Scientific Committee.
The ESC establishes the agenda, working methods, collaboration rules and performance indicators, and manages clinical trial selection to be carried out by the consortium. It also plays an advisory role in setting up the Programme Accès-recherche.
Segal Cancer Centre
Jewish General Hospital of the Integrated Health and Social Services University Network for West-Central Montreal
Assistant Professor, Department of Surgery & Associate Member, Department of Oncology,
Faculty of Medicine, McGill University
Dr. Louise Provencher
Medical Advisor for the Programme Accès-recherche
CHU de Québec – Université Laval
Late Dr. André Robidoux
Founding President of the Executive Scientific Committee
Centre hospitalier de l’Université de Montréal (CHUM)